Thus, the authors showed that GREM1 overexpression promotes proliferation and metastasis of glioma cells, while the use of miR-128-3p mimic inhibits the biological functions of glioma cells by targeting the GREM1 3′-UTR. The gene discussed is GREM1; the disease is central nervous system cancer.